Canada markets closed

22nd Century Group, Inc. (XXII)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
3.5200+0.5300 (+17.73%)
At close: 4:00PM EDT
3.5500 +0.03 (0.85%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close2.9900
Bid3.5500 x 900
Ask3.6200 x 1100
Day's Range3.0600 - 3.6000
52 Week Range0.5500 - 6.0700
Avg. Volume2,632,680
Market Cap572.236M
Beta (5Y Monthly)1.83
PE Ratio (TTM)N/A
EPS (TTM)-0.1480
Earnings DateNov. 03, 2021 - Nov. 08, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.00
  • GlobeNewswire

    22nd Century Group to Begin Trading on Nasdaq on August 16, 2021

    BUFFALO, N.Y., Aug. 05, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, announced today that its common stock has been approved for uplisting to the Nasdaq Capital Market effective as of the market open on August 16, 2021. The shares will continue to trade under the ticker symbol “XXII.” “While remaining dedicated to our primary mission to

  • Zacks

    22nd Century Group (XXII) Reports Q2 Loss, Tops Revenue Estimates

    22nd Century (XXII) delivered earnings and revenue surprises of 0.00% and 19.59%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    22nd Century Group Reports Business Highlights and Financial Results for the Second Quarter 2021

    Initiated International Launch Process For VLN®, First Sales Planned by First Quarter 2022First Revenue From Hemp/Cannabis Franchise to Commence in Second Half of 2021Third Plant-Based Franchise to be Introduced on August 30, 2021Uplisting common shares to the Nasdaq Capital Market (“Nasdaq”) and will continue to trade under current symbol, “XXII”Record Second Quarter Net Sales of $8.4 Million, Up Greater Than 30% From the Second Quarter of 2020Executing From a Strong Financial Position with Cas